Healthcare -
Biotechnology - NASDAQ - US
$ 4.43
-1.56 %
$ 376 M
Market Cap
-3.75
P/E
TERN - CASH FROM OPERATIONS
Cash from Operations TERN - Terns Pharmaceuticals, Inc.
-67.4 M
LAST VALUE
-26.93%
2 YEAR CAGR
-30.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR